v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue    
Total revenue $ 4,180 $ 1,102
Cost of revenue 2,514 775
Gross profit 1,666 327
Operating expenses:    
Research and development 5,263 1,530
Selling, general and administrative 21,291 6,749
Total operating expenses 26,554 8,279
Loss from operations (24,888) (7,952)
Other (expense) income:    
Foreign exchange transaction loss (3,725) (61)
Change in fair value of share liability 0 12
Change in fair value of convertible notes payable (568) (957)
Change in fair value of equity investments 1,126 0
Interest income 3,047 513
Interest expense (1,729) (87)
Total other expense (1,849) (580)
Loss before income tax benefit (26,737) (8,532)
Income tax benefit 31 71
Net loss from continuing operations (26,706) (8,461)
Income from discontinued operations, net of taxes 19,585 0
Net loss (7,121) (8,461)
Less: Net loss attributable to noncontrolling interests (243) (15)
Net loss attributable to ASP Isotopes Inc. shareholders $ (6,878) $ (8,446)
Net (loss) income per share, basic and diluted    
Net (loss) income per share, basic, Continuing operations $ (0.22) $ (0.12)
Net (loss) income per share, diluted, Continuing operations (0.22) (0.12)
Net (loss) income per share, basic, Discontinued operations 0.16 0
Net (loss) income per share, diluted, Discontinued operations 0.16 0
Net (loss) income per share, attributable to ASP Isotopes Inc. shareholders, basic (0.06) (0.12)
Net (loss) income per share, attributable to ASP Isotopes Inc. shareholders, diluted $ (0.06) $ (0.12)
Weighted average shares of common stock outstanding, basic 121,000,699 69,484,200
Weighted average shares of common stock outstanding, diluted 121,000,699 69,484,200
Comprehensive loss:    
Net loss before allocation to noncontrolling interests $ (7,121) $ (8,461)
Foreign currency translation (6,808) 1,171
Less: reclassification to earnings 1,496 0
Total comprehensive loss before allocation to noncontrolling interests (12,433) (7,290)
Less: Comprehensive loss attributable to noncontrolling interests (302) (1)
Total comprehensive loss (12,131) (7,289)
Product [Member]    
Revenue    
Total revenue 3,980 1,102
Collaboration Revenue [Member]    
Revenue    
Total revenue $ 200 $ 0